Many investors that are new to dividends tend to focus primarily on a stock’s dividend yield. This often leads to yield chasing, where an individual ignores factors such as payout ratio, dividend growth rate, and even company revenue growth in favor of buying whichever stocks pay the most right now. In this post, we’re going …
February was a volatile month for the markets, and a relatively an uneventful month for my portfolio. I didn’t make many moves, but am keeping an eye on my watch list for potential deals to open up in March. Buys and Sells In February, I added to my position in BlackRock (BLK), buying shares at …
After the FTC sued to block Lockheed’s deal for Aerojet Rocketdyne on January 25th, the acquisition was officially terminated on February 14th. If it had been successful, I think it would have been a great move for Lockheed, unlocking cost synergies and accelerating its space and missile segments. Unfortunately, current regulators felt such a deal …
Lockheed Martin – Revisiting the Failed Aerojet Acquisition Read More »
January was a pretty busy month for my dividend growth portfolio. Several of my holdings announced dividend increases, I made a few buys, and even sold out of one of my existing positions. Buys and Sells In January, I averaged down on my position in BlackRock (BLK), buying shares at $856.81, $771.54 and $783.73. I …
Entegris is a semiconductor equipment supplier that specializes in chemicals, micro contamination products, and advanced materials handling solutions. Their business model is primarily centered around foundry spending on a per-chip basis. This means demand for their products, and revenue, is heavily tied to the number of microprocessors being manufactured. Historically, the semiconductor industry has shown …
If you’re a dividend investor you’re probably quite familiar with AbbVie. The stock is known for its high dividend yield and high dividend growth, a combination that is rare in today’s stock market. The massive cash flows that have enabled such generous dividend increases are primarily fueled by one drug: Humira. With its loss of …
Lockheed Martin Corporation is one of the largest aerospace and defense companies in the world. It’s also one of the largest positions in my dividend growth portfolio. The stock is currently trading at what I would consider a fair valuation, making it an attractive choice in a market subject to volatility, speculation, and rising interest …
Lockheed Martin – In an Expensive Market, the Best Offense is Defense Read More »
Investing is a passion of mine. In particular, dividend growth investing. While it’s a cliché example, I often think about Warren Buffett’s investment in Coca-Cola and the dividends he collects annually. For reference, Buffett bought Coca-Cola stock several decades ago, and has a cost basis of about $3.25 per share (the stock is currently trading …
